Skip to content

Study on the effective dose of remimazolam combined with remifentanil for sedation during laryngoscopy with laryngeal mask airway in middle-aged and elderly patients

Study on the effective dose of remimazolam combined with remifentanil for sedation during laryngoscopy with laryngeal mask airway in middle-aged and elderly patients

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400081360
Enrollment
Unknown
Registered
2024-02-29
Start date
2024-03-01
Completion date
Unknown
Last updated
2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Respiratory disease

Interventions

The old group:Apply the corresponding dose of remimazolam during laryngoscope tracheoscopy
the adult group:Apply the corresponding dose of remimazolam during laryngoscope tracheoscopy

Sponsors

Shunde Hospital of Southern Medical University(The First People's Hospital of Shunde)
Lead Sponsor

Eligibility

Sex/Gender
All
Age
45 Years to 84 Years

Inclusion criteria

Inclusion criteria: 1: Age 45-89 years old, gender is not limited;2: Scheduled tracheoscopy surgery;3: ASA score of grade I-III;4: 18.0 kg/m2=BMI=30.0 kg/m2.

Exclusion criteria

Exclusion criteria: 1: Patients who refuse to participate or are not suitable for participating in this trial;2: Those who are allergic to the drugs used in the study;3: Patients with severe cardiovascular, pulmonary, hepatic, renal dysfunction or impaired adrenal cortical function;4: Preoperative hypertension patients with systolic blood pressure >180mmHg and/or diastolic blood pressure >110mmHg, or hypotension patients with systolic blood pressure <90/60mmHg;Patients with obstructive sleep apnea hypopnea syndrome or respiratory difficulties;6. Asthma patients;7. Those who have abused alcohol or taken psychotropic drugs or analgesics within 24 hours before surgery;8: have a history of chronic pain;9. Pregnancy or lactation;10. Psychological problems or mental illness history;11. Myasthenia gravis patients;

Design outcomes

Primary

MeasureTime frame
Heart rate;blood pressure;pulse oxygen condition;

Secondary

MeasureTime frame
The body reaction;

Countries

China

Contacts

Public ContactZhang Yiwen

Shunde Hospital of Southern Medical University(The First People's Hospital of Shunde)

ssss047@163.com+86 137 9464 7543

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026